ASSEMBLY BIOSCIENCES, INC. (ASMB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0453962070
ASSEMBLY BIOSCIENCES, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 72.30 m USD |
| Operating income | -12.12 m USD |
| EBIT | -6.12 m USD |
| Net income | -6.12 m USD |
| Diluted EPS – continuing operations | -0.55 USD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ASSEMBLY BIOSCIENCES, INC.
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.
More stocks
- Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367.SZ)
- NeuroPace Inc (NPCE)
- Beijing Haohan Data Technology Co. Ltd. A (688292.SS)
- Beijing Hanyi Innovation Technology Co. Ltd. A (301270.SZ)
- Zhong Fu Tong Co Ltd (300560.SZ)
- Beijing Jingxi Culture&Tourism Co Ltd (000802.SZ)
- Petpal Pet Nutrition Technology Co Ltd (300673.SZ)
- Clarity Pharmaceuticals Ltd (CU6.AX)
- Shaanxi Meineng Clean Energy Corp. Ltd. A (001299.SZ)
- Guangdong Transtek Medical Electronics Co Ltd (300562.SZ)
- Runa Smart Equipment Co. Ltd. (301129.SZ)
- Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd (300967.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.